The ‘Second Sex’ of harm reduction
From 2010 to 2020, opioid-related fatalities in women increased 46% faster than in men. While recent years have popularized harm reduction facilities such as safe injection and drug testing sites, marked differences between men and women have been systemically ignored in the assembly of drug-centred health care.